Rainer Blasczyk

Director/Prof. Dr.

Hannover Medical School

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Prof. Dr. Rainer Blasczyk is the Director at Hannover Medical School in Germany. His research primarily focuses on immunology and transplant biology, with recent articles addressing topics such as xenogeneic immune responses, antiviral T-cell enhancement, proteomic profiling of immune responses, and the role of novel immune receptors in transplantation settings. He is actively contributing to advancements in strategies for adoptive immunotherapy and the management of donor-specific anti-HLA antibodies in pediatric lung transplantation.

Articles (10)

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (2)

Constanca Figueiredo

Professor

Hannover Medical School

GERMANY

View details

Willem Wolkers

University of Veterinary Medicine Hannover

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Rainer Blasczyk

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Downregulation of Swine Leukocyte Antigen Expression Decreases the Strength of Xenogeneic Immune Responses towards Renal Proximal Tubular Epithelial Cells

HLA-B*57:01/Carbamazepine-10,11-Epoxide Association Triggers Upregulation of the NFκB and JAK/STAT Pathways

Enhancement of Antiviral T-Cell Responses by Vitamin C Suggests New Strategies to Improve Manufacturing of Virus-Specific T Cells for Adoptive Immunotherapy

Proteomic Profiling and T Cell Receptor Usage of Abacavir Susceptible Subjects

Unravelling the Proteomics of HLA-B*57:01<sup>+</sup> Antigen Presenting Cells during Abacavir Medication

Animal Models in Allogenic Solid Organ Transplantation

The Loss of HLA-F/KIR3DS1 Ligation Is Mediated by Hemoglobin Peptides

Towards Reduction or Substitution of Cytotoxic DMSO in Biobanking of Functional Bioengineered Megakaryocytes

NKG2A/CD94 Is a New Immune Receptor for HLA-G and Distinguishes Amino Acid Differences in the HLA-G Heavy Chain

Six-year experience with treatment of early donor-specific anti-HLA antibodies in pediatric lung transplantation using a human immunoglobulin-based protocol.

Collaborators (2)

Constanca Figueiredo

Willem Wolkers

Make your next move.